U.S. Hospital Phlebotomy Supplies: Top Distributors, Manufacturers, and Purchasing Guide

Summary

• Major U.S. sources for phlebotomy and blood collection products include national distributors such as McKesson, Medline, Cardinal Health, and Henry Schein, as well as manufacturers such as BD, Greiner Bio-One, Terumo, and SARSTEDT.
• Hospitals should evaluate suppliers based on product compatibility, regulatory documentation, inventory reliability, cold-chain capability, contract pricing, emergency fulfillment, and support for OSHA, CLIA, FDA, and infection-prevention requirements.
• A practical purchasing strategy usually combines a primary distributor, approved manufacturer contracts, and qualified backup suppliers for essential products such as evacuated tubes, needles, safety devices, Blood Culture supplies, and specimen-transport materials.

Hospitals in the United States purchase phlebotomy and blood collection products through a combination of national medical-supply distributors, specialized laboratory suppliers, direct manufacturer contracts, group purchasing organizations, and regional distributors. The product category extends well beyond needles and blood tubes. A typical hospital purchasing program may include evacuated blood collection tubes, Blood Culture bottles, safety needles, winged blood collection sets, syringes, tourniquets, alcohol and Chlorhexidine prep products, specimen labels, transport bags, tube racks, sharps containers, collection trays, capillary collection devices, and point-of-care specimen supplies.

The U.S. market is large and operationally complex. The American Hospital Association has reported that the country has more than 6,000 hospitals, including community hospitals, academic medical centers, specialty hospitals, and government facilities. Each facility may have different laboratory systems, electronic medical record workflows, formularies, contract arrangements, and patient populations. In addition, the Centers for Medicare & Medicaid Services regulates laboratory testing through the Clinical Laboratory Improvement Amendments, commonly called CLIA. As a result, hospitals do not select blood collection suppliers solely on the basis of unit price.

Product standardization, patient safety, Specimen Integrity, availability, and regulatory documentation are equally important. A low-cost tube is not necessarily economical if it causes recollection, invalid Test Results, analyzer incompatibility, or delays in laboratory processing. Similarly, a needle that performs well in routine adult collections may not be suitable for pediatric, geriatric, oncology, dialysis, or difficult-access patients.

How the U.S. Hospital Supply Market Is Organized

Hospitals generally obtain phlebotomy supplies through four purchasing channels. The first is a national distributor that maintains warehouses throughout the United States and delivers a broad portfolio of clinical products. The second is a direct relationship with a manufacturer, particularly for high-volume or technically specialized items. The third is a group purchasing organization, or GPO, which negotiates pricing and other contract terms for participating hospitals. The fourth is a regional or specialty distributor used for local service, emergency fulfillment, or products not included in a national contract.

Large integrated health systems often use all four channels. They may purchase standard needles and tubes under a systemwide contract, obtain Blood Culture products directly from a manufacturer, and maintain local distributors as backup sources. Smaller hospitals and critical access hospitals may rely more heavily on a full-service distributor because they do not have the purchasing staff or warehouse infrastructure required to manage numerous direct supplier relationships.

Purchasing decisions are also influenced by the GPO structure. Premier, Vizient, and HealthTrust are among the best-known GPOs serving U.S. hospitals and health systems. GPO participation can provide negotiated pricing, product standardization, benchmarking, and contract administration. However, a hospital must still validate products locally. A contract price does not replace clinical evaluation, laboratory verification, or an assessment of supply continuity.

Leading National Medical-Supply Distributors

McKesson Medical-Surgical

McKesson Medical-Surgical is one of the largest U.S. distributors of medical-surgical products. Its catalog commonly includes phlebotomy needles, safety-engineered blood collection devices, evacuated tubes, syringes, specimen containers, tourniquets, disinfectants, labels, sharps containers, and personal protective equipment.

McKesson is often considered by hospitals that want to consolidate routine purchases through one distribution account. Its broad catalog can be useful for emergency departments, outpatient laboratories, physician practices, ambulatory surgery centers, and inpatient units that need frequent replenishment. Depending on the product and contract, hospitals may obtain national-brand items or private-label alternatives.

When evaluating McKesson for blood collection supplies, hospitals should verify the specific manufacturer, tube additive, tube dimensions, lot tracking process, expiration dates, and compatibility with laboratory analyzers. A distributor may offer several products that appear similar but differ in Clot Activator, gel formulation, fill volume, plastic type, or intended specimen. Procurement teams should therefore compare the exact stock-keeping unit rather than relying only on a general product description.

Medline

Medline is another major U.S. medical-supply manufacturer and distributor. It supplies hospitals, health systems, outpatient clinics, long-term care organizations, and laboratories. Its portfolio includes safety needles, blood collection sets, tubes, specimen containers, disinfecting products, gloves, gowns, sharps containers, and other materials used in the collection Workflow.

Medline’s strength is its ability to combine distribution with private-label manufacturing and supply-chain services. Hospitals may be able to consolidate several categories under one contract, reducing the number of purchase orders and deliveries. Medline also works with facilities on inventory management, product standardization, and supply-chain programs.

For phlebotomy purchasing, a hospital should distinguish between products manufactured by Medline and products distributed by Medline on behalf of another company. The distinction matters when reviewing regulatory documentation, lot complaints, product recalls, technical support, and manufacturer change notifications. The hospital’s value analysis committee should also assess whether a proposed private-label product is clinically interchangeable with the product currently used.

Cardinal Health

Cardinal Health is a large healthcare services and distribution company that supplies hospitals, laboratories, physician offices, and other healthcare organizations. Its medical and laboratory offerings may include blood collection tubes, needles, blood collection sets, specimen transport products, syringes, antiseptics, personal protective equipment, and related consumables.

Cardinal Health is frequently relevant to large health systems that already use its distribution, pharmaceutical, or laboratory services. A systemwide account can simplify purchasing and provide access to contract pricing. Cardinal’s scale may also support scheduled deliveries, replenishment programs, and distribution to multiple hospital campuses.

Hospitals should confirm how backorders are handled, whether substitutions require prior approval, and how allocation decisions are made during national shortages. For critical blood collection items, the purchasing contract should clearly define notification procedures, acceptable substitutions, minimum shelf-life expectations, and escalation contacts.

Henry Schein

Henry Schein is best known for dental and office-based healthcare distribution, but it also supplies medical and laboratory products to outpatient practices, clinics, and smaller healthcare organizations. In some markets, Henry Schein may be a useful source for routine phlebotomy supplies, specimen containers, gloves, disinfectants, and related items.

Its role in a hospital’s sourcing strategy depends on facility size and product requirements. A large academic medical center may obtain most blood collection products through a dedicated hospital distributor or direct manufacturer agreement. A community clinic, physician practice, occupational-health center, or smaller outpatient laboratory may find a broadline distributor such as Henry Schein convenient for regular replenishment.

Fisher Scientific and Avantor

Fisher Scientific, part of Thermo Fisher Scientific, supplies a wide range of laboratory and clinical products. Its catalog can include specimen collection supplies, laboratory plastics, tubes, transport materials, labels, racks, disinfectants, and safety products. Fisher Scientific is particularly relevant when a hospital laboratory wants to combine clinical collection products with broader laboratory consumables.

Avantor, through its VWR business and other laboratory supply channels, also serves laboratories, healthcare institutions, and research organizations. It may provide specimen containers, laboratory plastics, transport supplies, personal protective equipment, and other materials used in preanalytical workflows.

These suppliers are often valuable for laboratory departments, research hospitals, reference laboratories, and facilities with diverse scientific purchasing requirements. Buyers should confirm that a product is cleared or intended for the applicable clinical use, rather than assuming that a laboratory-grade container is automatically suitable for a regulated diagnostic Workflow.

Major Manufacturers of Phlebotomy and Blood Collection Products

Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is one of the most prominent manufacturers in the U.S. blood collection market. Its portfolio includes evacuated blood collection tubes, needles, winged blood collection sets, safety-engineered devices, Blood Culture systems, capillary collection products, and specimen-management products.

BD products are widely used in hospitals and laboratories, making the company important when a facility wants broad analyzer compatibility and standardized training. Many hospitals use BD Vacutainer-branded products or evaluate them alongside competing systems. Product selection may include serum tubes, plasma tubes, Heparin tubes, EDTA tubes, citrate tubes, fluoride or glycolysis-inhibitor tubes, trace-element tubes, and specialized collection devices.

Because tube additives and tube order can affect test performance, hospitals should review the laboratory’s validated collection protocol before changing brands or product families. A change may require verification of specimen quality, fill volume, centrifugation requirements, analyzer performance, and reference intervals. The laboratory should also examine whether the change affects blood bank testing, coagulation testing, microbiology, molecular testing, or point-of-care workflows.

Greiner Bio-One

Greiner Bio-One is a major manufacturer of blood collection systems, including VACUETTE evacuated tubes, safety needles, blood collection sets, capillary products, urine collection products, and related laboratory supplies. Its products are used internationally and are available through U.S. distributors and direct commercial channels.

Greiner Bio-One is often considered by hospitals seeking an alternative to the dominant market supplier or looking to create competitive tension during Contract Negotiations. Its product range covers many routine tube types and collection accessories. Hospitals should compare tube materials, additive formulations, fill volumes, labeling, closure systems, and compatibility with existing instruments.

Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies supplies products used in blood collection, blood processing, transfusion medicine, and cellular therapies. Its portfolio is especially relevant to blood centers, transfusion services, and hospitals involved in blood component collection and processing. Products may include blood bags, collection systems, apheresis equipment, and associated disposable sets.

Terumo’s products are not limited to routine Venipuncture. Hospitals and blood centers may use them for whole-blood collection, component preparation, platelet collection, plasma collection, and therapeutic procedures. Purchasing teams should therefore distinguish between general phlebotomy supplies and specialized transfusion or apheresis products, which usually involve more extensive technical training, validation, and service requirements.

SARSTEDT

SARSTEDT manufactures specimen collection and laboratory products, including blood collection tubes, safety devices, capillary collection products, urine systems, specimen transport products, and laboratory consumables. Its products may be obtained by U.S. hospitals through direct sales or authorized distribution channels.

SARSTEDT can be relevant for facilities seeking specialized collection formats, pediatric or capillary sampling products, and alternatives to standard evacuated tube systems. As with any manufacturer change, a laboratory should evaluate the product under its own testing conditions and document approval through its quality-management process.

Nipro and Other Safety-Device Manufacturers

Nipro and other specialized manufacturers produce needles, safety-engineered blood collection devices, syringes, winged sets, and vascular-access products used in hospitals. The exact product mix varies by U.S. distribution agreements and clinical category.

Safety-engineered devices are particularly important because Needlestick Injuries remain a recognized occupational hazard. The Occupational Safety and Health Administration requires employers covered by the Bloodborne Pathogens Standard to use engineering and work-practice controls, maintain an exposure-control plan, and involve frontline workers in evaluating safer medical devices. A hospital’s evaluation should include activation method, visibility of the safety mechanism, one-handed use, tactile or audible confirmation, blood exposure risk, and usability with gloves.

Specialized Suppliers for Blood Collection and Laboratory Workflows

Not every product is purchased from a broadline medical distributor. Hospitals frequently use specialized suppliers for Blood Culture, transfusion medicine, specimen transport, blood bank, and laboratory automation requirements.

Blood Culture and Microbiology Products

Blood Culture collection requires products designed for microbiology testing rather than routine chemistry or hematology. Becton, Dickinson and Company provides the BACTEC Blood Culture system, while bioMérieux provides the BacT/ALERT system. These platforms include instrument-specific bottles and related supplies.

Blood Culture products must be selected together with the laboratory’s instrument platform. Substituting a bottle from another system may invalidate the test or compromise performance. Hospitals should also consider bottle storage conditions, expiration control, bottle inspection, transport time, skin antisepsis, collection volume, and contamination monitoring.

Blood Culture contamination is a major quality and cost concern. Published studies have often cited a target contamination rate of approximately 1 percent or less, although performance goals may vary by institution and patient population. Even a small increase in contamination can create additional laboratory testing, antibiotic exposure, imaging, admission days, and patient inconvenience. The collection device is only one part of the solution, but purchasing decisions should support standardized collection technique and staff training.

Blood Bank and Transfusion Supplies

Hospitals and blood centers purchase specialized collection bags, donor needles, sample tubes, labels, barcode systems, transport containers, and component-processing supplies. Terumo Blood and Cell Technologies, Fresenius Kabi, Haemonetics, and Macopharma are important companies in blood collection, blood processing, or transfusion-related markets, although their specific products and availability vary by facility and contract.

Blood bank products are subject to rigorous traceability requirements. A hospital should review lot numbers, expiration dates, sterilization information, storage requirements, labeling controls, and compatibility with the blood bank information system. Supplies used for donor collection and component processing may also require equipment service agreements, validated procedures, and manufacturer training.

Specimen Transport and Preanalytical Supplies

Companies such as Alcor Scientific, Globe Scientific, Puritan Medical Products, and other laboratory-supply manufacturers may provide specimen containers, swabs, transport tubes, collection devices, racks, and related materials. Some suppliers focus on specimen transport, while others provide plastics or sampling accessories.

Preanalytical errors occur before a specimen reaches the analyzer. Common problems include wrong patient identification, insufficient volume, hemolysis, clotting, incorrect tube type, delayed transport, temperature excursions, and improper mixing. Therefore, hospitals should evaluate transport bags, labels, pneumatic-tube compatibility, leak resistance, and packaging instructions as part of the overall blood collection system.

Products Hospitals Commonly Purchase

A hospital’s phlebotomy formulary often contains hundreds of individual stock-keeping units. The most frequently purchased categories usually include the following:

1. Evacuated blood collection tubes for serum, plasma, hematology, coagulation, chemistry, immunology, and specialized testing.
2. Safety blood collection needles in multiple gauges and lengths.
3. Winged blood collection sets for difficult access, pediatric patients, and short or fragile veins.
4. Syringe-based blood collection devices for situations in which an evacuated tube system is unsuitable.
5. Blood Culture bottles and collection accessories matched to the microbiology instrument platform.
6. Tourniquets, single-use or reusable, selected according to infection-prevention policy.
7. Alcohol pads, Chlorhexidine preparations, povidone-iodine products, and other approved skin antiseptics.
8. Gauze, adhesive bandages, cotton products, tape, and post-collection dressings.
9. Sharps containers and needle-disposal systems.
10. Specimen labels, barcode labels, printers, collection trays, tube racks, and transport bags.
11. Capillary Blood Collection devices for neonatal, pediatric, and Point-Of-Care Testing.
12. Personal protective equipment, including gloves, gowns, masks, and eye protection.

Hospitals should classify these products by clinical criticality. A shortage of a nonsterile tray may be inconvenient, while a shortage of safety needles, Blood Culture bottles, or citrate tubes can interrupt patient care and laboratory testing. Critical products need stronger inventory controls, higher safety stock, and documented alternative products.

Regulatory and Quality Considerations

The U.S. Food and Drug Administration regulates many medical devices used in blood collection. Depending on the device, regulatory controls may include establishment registration, device listing, premarket notification, quality-system requirements, labeling controls, and postmarket reporting. Buyers should request current regulatory and quality documentation when appropriate, especially for new or unfamiliar products.

CLIA also affects product selection because laboratories must use procedures and materials that support accurate and reliable testing. Under CLIA, laboratories are responsible for establishing quality systems, following manufacturer instructions, documenting procedures, and evaluating test performance. A tube or collection device that appears equivalent on paper may not be acceptable without laboratory verification.

The Clinical and Laboratory Standards Institute publishes widely used consensus standards covering venous and Capillary Blood Collection, specimen handling, order of draw, transportation, and other preanalytical practices. Although CLSI documents are not federal law, they are influential in laboratory quality programs and accreditation activities.

OSHA requirements are especially important for needles and other sharps. The Bloodborne Pathogens Standard emphasizes exposure prevention, employee training, engineering controls, and post-exposure procedures. The Needlestick Safety and Prevention Act strengthened the requirement to consider safer medical devices and to document input from nonmanagerial healthcare workers who use those devices.

Hospitals should also review accreditation expectations from organizations such as The Joint Commission, DNV, and other applicable accrediting bodies. Accreditation surveys may examine specimen identification, collection procedures, infection prevention, competency assessment, storage, and documentation. Supplier selection should support these requirements rather than treat them as separate from purchasing.

How Hospitals Should Compare Suppliers

Price is important, but it should be evaluated as total acquisition cost. Total cost may include unit price, freight, minimum order quantities, storage, product waste, staff training, equipment changes, analyzer validation, recollection, failed tests, and emergency purchasing.

A useful supplier scorecard can include the following criteria:

1. Product quality and documented regulatory status.
2. Compatibility with laboratory analyzers, Blood Culture systems, barcode systems, and pneumatic-tube transport.
3. Historical fill rates, backorder performance, and allocation policies.
4. Expiration dating and the supplier’s ability to provide adequate remaining shelf life.
5. Lot traceability, recall communication, and complaint handling.
6. Availability of safety-engineered alternatives and user training.
7. Contract pricing, rebates, freight terms, and minimum purchase requirements.
8. Emergency order capability and after-hours customer support.
9. Distribution-center locations and delivery frequency.
10. Environmental considerations, packaging reduction, and waste-management support.
11. Product standardization across inpatient, outpatient, emergency, and laboratory departments.
12. Implementation assistance, including competency training and collection-protocol support.

Hospitals should ask suppliers for several months of fill-rate and backorder data when available. They should also examine whether the supplier has experienced recalls, manufacturing interruptions, or allocation events involving the exact product category under review. A supplier with a strong general reputation may still have limitations in a particular product line.

Supply-Chain Risks and Resilience

The Covid-19 pandemic demonstrated how quickly demand can exceed production and distribution capacity for gloves, masks, tubes, swabs, syringes, and other clinical supplies. Blood collection products can also be affected by resin shortages, labor disruptions, transportation problems, manufacturing-site incidents, natural disasters, and sudden increases in testing volume.

Hospitals should not rely on a single source for every critical item. Dual sourcing can reduce risk, but it must be managed carefully. Different brands may use different tube additives, needle designs, packaging, or barcode formats. A backup product should therefore be evaluated before an emergency occurs.

Resilience planning may include maintaining a defined number of days of supply, setting reorder points based on actual usage, monitoring supplier allocation notices, and keeping approved substitutions in the laboratory’s formulary. Inventory targets should reflect demand variability and product shelf life. Excess inventory can expire, while insufficient inventory can force expensive spot purchases.

Hospitals should also identify products that are vulnerable to substitution. Blood Culture bottles, coagulation tubes, specialized trace-element tubes, and blood bank supplies may have limited alternatives. These products deserve separate contingency plans and executive visibility.

Direct Manufacturer Purchasing Versus Distribution

Direct purchasing can be attractive for high-volume hospitals because it may provide lower pricing, technical support, product training, and direct access to manufacturer representatives. It may also improve communication about product changes and recalls. However, direct contracts can increase administrative work, require larger order quantities, and create additional freight or receiving requirements.

Distributor purchasing provides convenience and consolidation. One distributor can supply products from numerous manufacturers and deliver them on a regular schedule. This approach can reduce the number of invoices and simplify replenishment. The tradeoff is that the hospital may have less control over product allocation and may pay a distribution margin.

Many hospital systems use a hybrid model. Routine supplies are ordered through a national distributor, while high-volume or specialized products are purchased under direct manufacturer contracts. This approach can balance efficiency, pricing, product expertise, and resilience.

Practical Purchasing Process for a U.S. Hospital

A disciplined purchasing project should begin with a utilization review. The hospital should determine how many venipunctures, blood cultures, coagulation tests, transfusion procedures, and capillary collections occur each month. Usage should be separated by department because emergency, inpatient, outpatient, pediatric, oncology, dialysis, and laboratory areas may need different products.

The next step is a clinical and technical assessment. Phlebotomists, nurses, laboratory scientists, infection-prevention professionals, supply-chain staff, and occupational-health representatives should participate. Frontline users can identify issues that may not appear in a catalog, such as difficult safety activation, tube breakage, excessive vacuum, poor labeling surfaces, or packaging that slows collection.

Hospitals should then request samples and conduct a structured evaluation. The evaluation may measure first-stick success, patient comfort, specimen quality, tube breakage, hemolysis, safety-device activation, ease of disposal, and staff acceptance. Laboratory verification should be performed whenever a product could affect Test Results or specimen processing.

After evaluation, the hospital can issue a request for proposal or negotiate through its GPO. The final contract should address pricing, delivery commitments, shortage notifications, substitution rules, product changes, recalls, returns, expiration dating, data reporting, and service levels.

Implementation requires more than replacing a product in the storeroom. The hospital may need revised policies, updated order sets, new barcode records, staff education, competency documentation, laboratory validation, and communication to every department that collects or handles blood specimens.

Conclusion

U.S. hospitals can purchase phlebotomy and blood collection products from national distributors such as McKesson, Medline, Cardinal Health, Henry Schein, Fisher Scientific, and Avantor, while sourcing specialized products directly from manufacturers such as BD, Greiner Bio-One, Terumo Blood and Cell Technologies, SARSTEDT, Nipro, Fresenius Kabi, Haemonetics, bioMérieux, and other qualified companies.

The best supplier depends on the hospital’s size, clinical services, laboratory platforms, contract structure, geographic location, and risk tolerance. National distributors provide breadth and convenience, while direct manufacturers often provide deeper technical expertise and specialized products. GPOs can improve contract economics, but hospitals remain responsible for product validation and patient-safety decisions.

A successful purchasing program treats blood collection supplies as part of the laboratory and patient-care system. Hospitals should evaluate the complete Workflow—from patient identification and skin preparation through collection, labeling, transport, testing, and disposal. By combining qualified suppliers, validated products, reliable inventory controls, and feedback from frontline staff, U.S. hospitals can reduce preanalytical errors, protect healthcare workers, and maintain continuity of care.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos